Eli Lilly 2Q profit falls 11 percent

[July 21, 2011]  INDIANAPOLIS (AP) -- Eli Lilly says its second-quarter net income fell 11 percent, as an increase in marketing, selling and administrative expenses blunted the drugmaker's revenue growth.

The Indianapolis company says it earned $1.2 billion, or $1.07 per share, in the three months that ended June 30. That's down from the $1.35 billion, or $1.22 per share, Lilly earned in the same quarter last year. Revenue rose 9 percent to $6.25 billion.

Excluding charges, profit was $1.18 per share.

Analyst expected earnings of $1.19 per share on $6.01 billion in revenue.

Sales for Lilly's best-selling drug, the antipsychotic Zyprexa, climbed 12 percent to $1.41 billion. The company will lose U.S. patent protection for the blockbuster drug in October.

[Associated Press]

Copyright 2011 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.